Matches in SemOpenAlex for { <https://semopenalex.org/work/W1982198648> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W1982198648 endingPage "S14" @default.
- W1982198648 startingPage "S10" @default.
- W1982198648 abstract "Assessing the combination of docetaxel with cisplatin or carboplatin was based on their activity as single agents, their nonoverlapping toxicity profiles, and their lack of cross-resistance. Phase I studies of docetaxel in combination with cisplatin established that 75 mg/m2 of each agent could be administered with reasonable safety and appeared to be active in non small-cell lung cancer (NSCLC). We evaluated the docetaxel/cisplatin combination in patients with advanced NSCLC. The response rate was 32%, and the median survival was 11.5 months. Efficacy was comparable to that observed in the Australian and French trials with the same combination. This is now being evaluated further in two large randomized trials for patients with advanced NSCLC and has been incorporated into the combined modality programs for early-stage disease. Carboplatin, devoid of the nephrotoxicity and neurotoxicity associated with the parent cis-platin, was then combined with docetaxel. The recommended dose of docetaxel for further evaluation in combination with carboplatin (AUC=6 mg/mL.min) was 90 mg/m2 with filgrastim support and 80 mg/m2 without filgrastim support. Our phase II trial of the combination of docetaxel and carboplatin in advanced NSCLC demonstrated an overall response rate of 36%; median survival was 13.9 months, and 1-year survival was 52%. Comparable activity has been seen by other investigators, and the regimen is being evaluated in two randomized trials. The combination of docetaxel with either of the two platinum agents has reasonable activity in NSCLC, though the carboplatin/docetaxel doublet appears to have a better therapeutic index." @default.
- W1982198648 created "2016-06-24" @default.
- W1982198648 creator A5015680000 @default.
- W1982198648 date "2000-04-01" @default.
- W1982198648 modified "2023-10-01" @default.
- W1982198648 title "Docetaxel in Combination with Platinum Compounds for Non–Small-Cell Lung Cancer" @default.
- W1982198648 cites W1826360242 @default.
- W1982198648 cites W1865725105 @default.
- W1982198648 cites W1883066466 @default.
- W1982198648 cites W1885385133 @default.
- W1982198648 cites W1903757011 @default.
- W1982198648 cites W1909306097 @default.
- W1982198648 cites W1917502393 @default.
- W1982198648 cites W1959295051 @default.
- W1982198648 cites W1967832506 @default.
- W1982198648 cites W1972010711 @default.
- W1982198648 cites W1977291222 @default.
- W1982198648 cites W1983042427 @default.
- W1982198648 cites W1995582426 @default.
- W1982198648 cites W2028940434 @default.
- W1982198648 cites W2038805809 @default.
- W1982198648 cites W2045645173 @default.
- W1982198648 cites W2058978290 @default.
- W1982198648 cites W2065357784 @default.
- W1982198648 cites W2079171343 @default.
- W1982198648 cites W2087884039 @default.
- W1982198648 cites W2113574953 @default.
- W1982198648 cites W2128746268 @default.
- W1982198648 cites W2134055831 @default.
- W1982198648 cites W2149463127 @default.
- W1982198648 cites W2158559013 @default.
- W1982198648 cites W2262127979 @default.
- W1982198648 cites W2465040813 @default.
- W1982198648 cites W2504684570 @default.
- W1982198648 doi "https://doi.org/10.3816/clc.2000.s.002" @default.
- W1982198648 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14725736" @default.
- W1982198648 hasPublicationYear "2000" @default.
- W1982198648 type Work @default.
- W1982198648 sameAs 1982198648 @default.
- W1982198648 citedByCount "2" @default.
- W1982198648 crossrefType "journal-article" @default.
- W1982198648 hasAuthorship W1982198648A5015680000 @default.
- W1982198648 hasConcept C126322002 @default.
- W1982198648 hasConcept C143998085 @default.
- W1982198648 hasConcept C2776256026 @default.
- W1982198648 hasConcept C2776694085 @default.
- W1982198648 hasConcept C2778239845 @default.
- W1982198648 hasConcept C2781190966 @default.
- W1982198648 hasConcept C2781413609 @default.
- W1982198648 hasConcept C2781451048 @default.
- W1982198648 hasConcept C71924100 @default.
- W1982198648 hasConcept C98274493 @default.
- W1982198648 hasConceptScore W1982198648C126322002 @default.
- W1982198648 hasConceptScore W1982198648C143998085 @default.
- W1982198648 hasConceptScore W1982198648C2776256026 @default.
- W1982198648 hasConceptScore W1982198648C2776694085 @default.
- W1982198648 hasConceptScore W1982198648C2778239845 @default.
- W1982198648 hasConceptScore W1982198648C2781190966 @default.
- W1982198648 hasConceptScore W1982198648C2781413609 @default.
- W1982198648 hasConceptScore W1982198648C2781451048 @default.
- W1982198648 hasConceptScore W1982198648C71924100 @default.
- W1982198648 hasConceptScore W1982198648C98274493 @default.
- W1982198648 hasLocation W19821986481 @default.
- W1982198648 hasLocation W19821986482 @default.
- W1982198648 hasOpenAccess W1982198648 @default.
- W1982198648 hasPrimaryLocation W19821986481 @default.
- W1982198648 hasVolume "1" @default.
- W1982198648 isParatext "false" @default.
- W1982198648 isRetracted "false" @default.
- W1982198648 magId "1982198648" @default.
- W1982198648 workType "article" @default.